Experienced in Anemia

Dr. Peter Coccia

Hematology
University Of Nebraska Medicine
4400 Emile St Fl 3, 
Omaha, NE 
Experienced in Anemia
University Of Nebraska Medicine
4400 Emile St Fl 3, 
Omaha, NE 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Peter Coccia is a Hematologist in Omaha, Nebraska. Dr. Coccia is rated as an Experienced provider by MediFind in the treatment of Anemia. His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Aplastic Anemia, and Tetrasomy X.

His clinical research consists of co-authoring 23 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Anemia.

Specialties
Hematology
Licenses
Pediatric Hematology-Oncology in NE
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

University of Nebraska Medicine
4400 Emile St Fl 3, Omaha, NE 68198
Call: 402-559-4208

Additional Areas of Focus

Dr. Coccia has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
Enrollment Status: Active_not_recruiting
Publish Date: October 27, 2025
Intervention Type: Drug, Radiation, Biological, Other
Study Drugs: Carboplatin, Cisplatin, Cyclophosphamide, Etoposide, Vincristine
Study Phase: Phase 3
A Comprehensive Approach to Improve Medication Adherence in Pediatric ALL
A Comprehensive Approach to Improve Medication Adherence in Pediatric ALL
Enrollment Status: Active_not_recruiting
Publish Date: September 22, 2025
Intervention Type: Drug, Behavioral, Other, Procedure
Study Drug: 6-Mercaptopurine
Study Phase: Phase 3
Neuropsychological, Social, Emotional, and Behavioral Outcomes in Children With Cancer
Neuropsychological, Social, Emotional, and Behavioral Outcomes in Children With Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 18, 2025
Intervention Type: Other, Procedure
A Phase III Open-Label Trial of Caspofungin vs. Azole Prophylaxis for Patients at High-Risk for Invasive Fungal Infections (IFI) Following Allogeneic Hematopoietic Cell Transplantation (HCT)
A Phase III Open-Label Trial of Caspofungin vs. Azole Prophylaxis for Patients at High-Risk for Invasive Fungal Infections (IFI) Following Allogeneic Hematopoietic Cell Transplantation (HCT)
Enrollment Status: Completed
Publish Date: October 16, 2024
Intervention Type: Drug, Other
Study Phase: Phase 3
A COG Study for Collecting and Banking Ewing Sarcoma Specimens
A COG Study for Collecting and Banking Ewing Sarcoma Specimens
Enrollment Status: Completed
Publish Date: October 03, 2023
Intervention Type: Other
A Randomized Open-Label Trial of Caspofungin Versus Fluconazole to Prevent Invasive Fungal Infections in Children Undergoing Chemotherapy for Acute Myeloid Leukemia (AML)
A Randomized Open-Label Trial of Caspofungin Versus Fluconazole to Prevent Invasive Fungal Infections in Children Undergoing Chemotherapy for Acute Myeloid Leukemia (AML)
Enrollment Status: Completed
Publish Date: March 30, 2021
Intervention Type: Drug, Other
Study Phase: Phase 3
View 5 Less Clinical Trials

23 Total Publications

Guidelines Insights: Acute Lymphoblastic Leukemia, Version 1.2019.
Guidelines Insights: Acute Lymphoblastic Leukemia, Version 1.2019.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: May 16, 2019
View All 23 Publications
Similar Doctors
Distinguished in Anemia
Dr. Robert M. Langdon
Hematology Oncology | Oncology | Hematology
Distinguished in Anemia
Dr. Robert M. Langdon
Hematology Oncology | Oncology | Hematology

Oncology Hematology West, PC

7500 Mercy Rd, Suite 1300, 
Omaha, NE 
 (3.1 miles away)
402-393-3110
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Robert Langdon is a Hematologist Oncology specialist and an Oncologist in Omaha, Nebraska. Dr. Langdon is rated as a Distinguished provider by MediFind in the treatment of Anemia. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Lung Cancer, Pleuropulmonary Blastoma, and Bone Marrow Aspiration. Dr. Langdon is currently accepting new patients.

Advanced in Anemia
Dr. Irina Popa
Hematology | Oncology
Advanced in Anemia
Dr. Irina Popa
Hematology | Oncology
8303 Dodge St, #225, 
Omaha, NE 
 (3.4 miles away)
402-354-5860
Languages Spoken:
English
See accepted insurances

Irina Popa is a Hematologist and an Oncologist in Omaha, Nebraska. Dr. Popa is rated as a Distinguished provider by MediFind in the treatment of Anemia. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Colorectal Cancer, and Hemangioma Thrombocytopenia Syndrome.

Distinguished in Anemia
Dr. Muhammad S. Haroon
Hematology Oncology | Oncology | Hematology
Distinguished in Anemia
Dr. Muhammad S. Haroon
Hematology Oncology | Oncology | Hematology

Oncology Hematology West, PC

450 E 23rd St, 
Fremont, NE 
 (30.0 miles away)
402-941-7030
Languages Spoken:
English, Urdu
See accepted insurances
Accepting New Patients

Muhammad Haroon is a Hematologist Oncology specialist and an Oncologist in Fremont, Nebraska. Dr. Haroon is rated as a Distinguished provider by MediFind in the treatment of Anemia. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, and Chronic Lymphocytic Leukemia (CLL). Dr. Haroon is currently accepting new patients.

VIEW MORE ANEMIA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Coccia's expertise for a condition
ConditionClose
        • Experienced
        • Acute Lymphoblastic Leukemia (ALL)
          Dr. Coccia is
          Experienced
          . Learn about Acute Lymphoblastic Leukemia (ALL).
          See more Acute Lymphoblastic Leukemia (ALL) experts
        • Anemia
          Dr. Coccia is
          Experienced
          . Learn about Anemia.
          See more Anemia experts
        • Aplastic Anemia
          Dr. Coccia is
          Experienced
          . Learn about Aplastic Anemia.
          See more Aplastic Anemia experts
        • Leukemia
          Dr. Coccia is
          Experienced
          . Learn about Leukemia.
          See more Leukemia experts
        • Tetrasomy X
          Dr. Coccia is
          Experienced
          . Learn about Tetrasomy X.
          See more Tetrasomy X experts
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile
        For Patients
        • Our Story
        • How MediFind Works
        • Conditions A-Z
        • Doctor Directory
        • Symptoms Directory
        • Procedures Directory
        • Treatment Directory
        • Drug Directory
        • Infusion Center Finder
        • FAQ
        • Contact Us
        For Providers and Practices
        • Claim Your Profile
        • Newsroom
        Business Solutions
        • Provider
        • Network Solutions
        Additional Resources
        • Consumer Health Data Privacy Policy
        • Privacy Policy
        • Terms of Use
        • Advertising Policy
        • Content Policy
        Subscribe to our newsletter

        Sign up to stay informed about MediFind and get wellness sent your way.

        Close

          By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

          Bullet PinMediFind
          Follow us on
          This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
          © 2026 All Rights Reserved

          Request an Appointment

          If you are experiencing a medical emergency, call 9-1-1.

          MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

          Patient Details

          This information is for the patient who will be seen at the appointment.

            Close

            Returning patient? Use your address on file with the provider.

            Insurance Details

            Please provide information of the primary insurance holder as the practice may require this information to schedule.

            Insurance Provider *
            Insurance ProviderClose

            Appointments Details

            Let’s get more information about your appointment.

                    0 / 1000
                    0 / 1000
                    By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.